This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancerAstraZeneca, Harbour BioMed join hands to discover, develop next-generation therapeutic antibodies
Raid in Paschim Vihar: Counterfeit medicine racket bustedWith Rs 3,788 Crore in Savings, Govt Eyes Adding More Drugs Under NLEM
Sun Pharma, Incyte settle dispute over LEQSELVIVasudha Pharma Chem, execs charged in US for illegal fentanyl precursor imports
AstraZeneca Imfinzi gets USFDA priority reviewSMS Pharma gets one USFDA observation for Bachupally facility
Lupin Digital Health introduces Post-Procedure Home-Based Care GuideLupin Digital Health introduces Post-Procedure Home-Based Care Guide
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerBiocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancerAstraZeneca to inject USD 2.5 billion in new RnD centre, biotech pacts, manufacturing in Beijing
Sun Pharma Gets Relief As Delhi HC Bars Use of BERIVITAL, BEZOLIC, DOZE-30 For Trademark InfringementProtocol doesn't address all aims of phase IV CT: CDSCO Panel Tells Sun Pharma Lab on Esomeprazole...
Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom TabletsMankind Pharma gets CDSCO Panel nod for bioequivalence study of Resmetirom Tablets
Raid at quack clinic in Telangana, drugs seizedRaid at quack clinic in Telangana, drugs seized
Action taken against 694 manufacturing units since 2022: MinisterUnlicensed premises operating illegally without drug license, stock worth Rs 43000 seized
Roche announces topline results from trials investigating astegolimab compared to placebo in COPD patientssubmit phase I and phase II data for Crohn's disease: CDSCO Panel tells Roche Products India on...
X